中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2014年
11期
1000-1001,1005
,共3页
谢榕%郑雄伟%陈刚%刘桐宇%何诚%林玉珍%杨琳%李桑%Lulu ZHANG
謝榕%鄭雄偉%陳剛%劉桐宇%何誠%林玉珍%楊琳%李桑%Lulu ZHANG
사용%정웅위%진강%류동우%하성%림옥진%양림%리상%Lulu ZHANG
人乳头瘤病毒%支链DNA信号扩增技术%细胞学%E6/E7信使RNA
人乳頭瘤病毒%支鏈DNA信號擴增技術%細胞學%E6/E7信使RNA
인유두류병독%지련DNA신호확증기술%세포학%E6/E7신사RNA
human papilloma virus%branched DNA signal amplification assay%cytology%E6/E7 mRNA
目的:评价支链 DNA ( bDNA )技术检测高危人乳头瘤病毒外显子6/7(HPV E6/E7)mRNA对宫颈癌筛查的意义。方法用bDNA技术在335例液基细胞学标本(经活检确认病理92例)检测HPV E6/E7 mRNA,其中93例同时检测E6/E7 DNA;对mRNA在不同病理级别分布情况进行分析。结果随着宫颈病变程度加重,HPV E6/E7 mRNA表达率相应增加。 E6/E7 DNA与RNA间受试者工作特征曲线( ROC )分析,预测 CIN2+病变的最佳工作点为530.53 copies· mL-1,ROC曲线下面积为0.789。结论 bDNA技术检测在液基细胞学标本中可很好地检测HPV E6/E7 mRNA。高危HPV E6/E7 mRNA检测的良好阳性似然比可用于宫颈癌筛查,其拷贝值可作为预测宫颈病变的指标。
目的:評價支鏈 DNA ( bDNA )技術檢測高危人乳頭瘤病毒外顯子6/7(HPV E6/E7)mRNA對宮頸癌篩查的意義。方法用bDNA技術在335例液基細胞學標本(經活檢確認病理92例)檢測HPV E6/E7 mRNA,其中93例同時檢測E6/E7 DNA;對mRNA在不同病理級彆分佈情況進行分析。結果隨著宮頸病變程度加重,HPV E6/E7 mRNA錶達率相應增加。 E6/E7 DNA與RNA間受試者工作特徵麯線( ROC )分析,預測 CIN2+病變的最佳工作點為530.53 copies· mL-1,ROC麯線下麵積為0.789。結論 bDNA技術檢測在液基細胞學標本中可很好地檢測HPV E6/E7 mRNA。高危HPV E6/E7 mRNA檢測的良好暘性似然比可用于宮頸癌篩查,其拷貝值可作為預測宮頸病變的指標。
목적:평개지련 DNA ( bDNA )기술검측고위인유두류병독외현자6/7(HPV E6/E7)mRNA대궁경암사사적의의。방법용bDNA기술재335례액기세포학표본(경활검학인병리92례)검측HPV E6/E7 mRNA,기중93례동시검측E6/E7 DNA;대mRNA재불동병리급별분포정황진행분석。결과수착궁경병변정도가중,HPV E6/E7 mRNA표체솔상응증가。 E6/E7 DNA여RNA간수시자공작특정곡선( ROC )분석,예측 CIN2+병변적최가공작점위530.53 copies· mL-1,ROC곡선하면적위0.789。결론 bDNA기술검측재액기세포학표본중가흔호지검측HPV E6/E7 mRNA。고위HPV E6/E7 mRNA검측적량호양성사연비가용우궁경암사사,기고패치가작위예측궁경병변적지표。
Objective To investigate the role of testing E6/E7 mRNA of high risk human papilloma virus ( HPV) for cervical cancer screening by branched DNA(bDNA)technology.Methods Branched DNA(bD-NA) technology was used to detect high-risk HPV E6/E7 mRNA and DNA directly from 335 liquid cytologic test(LCT) samples(91 samples were recognized by histopathology).Both of mRNA and DNA were detec-ted in 93 samples.The data according to cytological grades or pathology were statistically analyzed.Results The expression level of HPV E6/E7 mRNA transcripts elevated corresponding to the degree of cervical dyspla-sia.Receiver operating characteristic( ROC) curve was analyzed for pre-dicting CIN2 +, the optimal operating point value was 530.53 copies· mL-1.Conclusion bDNA technology can be used to detect HPV E6/E7 mRNA well in LCT samples.HPV E6/E7 mRNA test could be a useful tool for cervical cancer screening for its positive likelihood ratio.The copies of mRNA may be used to pool out high-risk patient in cervical cancer screening.